SYSTEMIC-SCLEROSIS IN THE ELDERLY

被引：21

作者：

CZIRJAK, L

NAGY, Z

SZEGEDI, G

机构：

[1] 3rd Department of Medicine, University Medical School of Debrecen

来源：

CLINICAL RHEUMATOLOGY | 1992年 / 11卷 / 04期

关键词：

SCLERODERMA; SYSTEMIC SCLEROSIS; OLD ONSET; CLINICAL STUDY;

D O I：

10.1007/BF02283102

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In our study, the characteristics of 114 patients with systemic sclerosis (SSc) are discussed with emphasis on the subgroup of cases whose onset of disease occurred above the age of 60 years. Seven out of the 9 cases showed symptoms of diffuse cutaneous systemic sclerosis with an extensive skin involvement, and 5 of these cases died within 2 years following the onset of SSc. Seven of the 9 cases showed a rapid disease course with symptoms of cardiac, pulmonary and/or renal involvement, while no secondary Sjogren's syndrome, subcutaneous calcinosis and myositis were demonstrated among these patients.

引用

页码：483 / 485

页数：3

共 19 条

[1]

Czirjak L., Schlammadinger J., Szegedi G., Anticentromere antibody and Raynaud phenomenon, Dermatologica, 183, (1991)

[2]

Czirjak L., Bokk A., Csontos G., Lorincz G., Szegedi G., Clinical findings in patients with progressive systemic sclerosis, Acta Derm Venereol (Stockh.), 69, pp. 533-36, (1989)

[3]

Lally E.V., Jimenez S.A., Kaplan S.R., Progressive systemic sclerosis: mode of presentation, rapidly progressive disease course, and mortality based on an analysis of 91 patients, Semin Arthritis Rheum, 18, pp. 1-13, (1988)

[4]

Preliminary criteria for the classification of systemic sclerosis (scleroderma), Arthritis Rheum, 23, pp. 581-590, (1980)

[5]

LeRoy C.E., Krieg T., Black C., Medsger T.A., Fleischmajer R., Rowell N., Jablonska S., Wollheim F., Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis (editorial), J Rheumatol, 15, pp. 202-205, (1988)

[6]

Tamasi L., Dezsi A., Sonkoly I., Kiss E., Balazs C., Szegedi G., Examination of the epidemiology of immunopathological diseases in inhabitats of Hajdu-Bihar county, Orvosi Hetilap, 128, pp. 2101-2105, (1987)

[7]

Medsger T.A., Masi A.T., Rodnan G.P., Benedek T.G., Robinson, Survival with systemic sclerosis (scleroderma): A lifetable analysis of clinical and demographic factors in 309 patients, Ann Intern Med, 75, pp. 369-37, (1971)

[8]

Wynn J., Fineberg N., Matzer L., Cortada X., Artrong W., Dillon C., Kinney E., Prediction of survival in progressive systemic sclerosis by multivariate analysis of clinical features, Am Heart J, 110, pp. 123-12, (1985)

[9]

Barnett A.J., Scleroderma (Progressive systemic sclerosis): Progress and course based on a personal series of 118 cases, Med J Aust, 2, pp. 129-134, (1978)

[10]

Bennett R., Bluestone R., Holt P.J.L., Bywaters E.G.L., Survival in scleroderma, Ann Rheum Dis, 30, pp. 581-588, (1971)

← 1 2 →